PDF(Pubmed)
Abstract：
Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an adaptative response to higher pressures of the arterial circulation. The VESTTM device (Vascular Graft Solutions, Tel Aviv, Israel), an external support designed to mitigate intimal hyperplasia in SVGs, has been tested in few clinical trials (RCTs). Herein, we descriptively evaluated the randomized evidence on the VEST device.
摘要：
大隐静脉移植物（SVG）是冠状动脉旁路移植术（CABG）中最常用的导管，但与动脉导管相比，它们的闭塞率更高仍然是一个问题。以前的研究表明，SVG衰竭主要是由内膜增生引起的，对动脉循环高压的适应性反应。VESTTM设备(血管移植解决方案,特拉维夫,以色列),旨在减轻SVG内膜增生的外部支架，已经在少数临床试验（RCTs）中进行了测试。在这里，我们描述性地评估了VEST装置上的随机证据.
